Capital World Investors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46.7M Buy
590,612
+16,112
+3% +$1.37M 0.01% 486
2026
Q1
$49.5M Hold
574,500
0.01% 458
2025
Q4
$50.2M Hold
574,500
0.01% 411
2025
Q3
$32.9M Hold
574,500
﹤0.01% 454
2025
Q2
$33.9M Hold
574,500
﹤0.01% 446
2025
Q1
$42.1M Hold
574,500
0.01% 412
2024
Q4
$47.5M Hold
574,500
0.01% 403
2024
Q3
$41.1M Hold
574,500
0.01% 409
2024
Q2
$39.3M Hold
574,500
0.01% 402
2024
Q1
$30.8M Hold
574,500
0.01% 427
2023
Q4
$30.6M Hold
574,500
0.01% 415
2023
Q3
$28.5M Buy
+574,500
New +$32.1M 0.01% 417

Other funds holding GMED

Capital World Investors's GMED Position: Q2 2026 in Review

Capital World Investors increased its Globus Medical (GMED) stake by 2.8% in Q2 2026, buying an estimated $1.37M and bringing the position to 590,612 shares worth $46.7M. The position accounts for 0.01% of the portfolio, ranked #486.

Capital World Investors first reported a position in GMED in Q3 2023 and has held it in 12 quarters since. The position peaked at $50.2M in Q4 2025. 597 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Capital World Investors held 590,612 shares of Globus Medical worth $46.7M as of Q2 2026.
  • Capital World Investors bought 16,112 Globus Medical shares in Q2 2026, an estimated $1.37M.
  • Globus Medical made up 0.01% of Capital World Investors's portfolio in Q2 2026, its #486 holding.
  • Capital World Investors first reported a position in Globus Medical in Q3 2023 and has held it in 12 quarters since.
  • Capital World Investors's Globus Medical position peaked at $50.2M in Q4 2025.
  • 597 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Capital World Investors's 13F filing for Q2 2026, filed 12 Aug 2026.